Vaccine Treatment for Advanced Malignant Melanoma
Clinical trial NCT00300612 · COMPLETED
Trial details
- NCT number
- NCT00300612
- Sponsor
- NewLink Genetics Corporation
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-03-01
- Primary completion
- 2007-09-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.